All Type of News
Pharmacists oppose partial prescription measure
The Korean Pharmaceutical Association (KPA) and the government have clashed over an exceptional drug dispensing measures, under which doctors or dentists are able to dispense five prescription drugs, such as analgesti...
KFDA inspection of small drug package system imminent
The Korea Food and Drug Administration will conduct an inspection of pharmaceutical firms over the compulsory small package system.
Sources said the drug agency will work out measures to ensure more flexible produc...
Iressa has expanded health insurance coverage
Insurance coverage for Iressa (gefitinib), a targeted oral anti-cancer drug, has been expanded to patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK (e...
Bukwang to start preclinical trial for new VEGF inhibitor
Bukwang Pharm said on September 28 it will commence animal experiments for apatinib mesylate, a novel Vascular Endothelial Growth Factor (VEGF) inhibitor and complete the tests in the first half of next year.
To th...
Wholesalers defy Zuellig Korea
Boksan Pharm, a local wholesaler in Pusan, announced on September 29 that it will discontinue a business relationship with Zuellig Korea, following Dongwon and Chungsipja.
Other leading wholesalers, such as Geoyoun...
90% of Korean patients take Tamiflu for prevention of swine flu
The majority of Korean patients had Tamiflu for the prevention of the new influenza A, even in absence of common cold and fever, according to Rep. Shim Jae-chul who cited a report released by the Food and Drug Adminst...
Multinationals expressing discontent over Korea’s drug price reform
The Korean government’s Drug Price Reform plan would limit Korean patients’ access to newly-developed drugs which might cure them, according to a report released by the Korean-based Pharmaceutical Industry Association...
Novartis is in consensus with wholesalers over direct transaction
Novartis Korea and pharmaceutical wholesalers were in agreement that joint efforts are required to promote a direct deal between wholesalers and Novartis.
“Novartis Korea will seek to foster more fair competition i...
US FDA OKs clinical trial on stem cell
CJ Cheil Jedang says the U.S. Food and Drug Administration has allowed its U.S. partner Neuralstem Inc. to start an early-stage human trial of its spinal cord stem cells in Lou Gehrig's disease, a fatal neuromuscular ...
Concerns growing over Korea’s drug price reform
A new wave of price cuts for drugs is speculated to be imminent in Korea, which has stirred up concerns among pharmaceutical firms, multinational and domestic alike.
So far the details of the nation’s drug price re...
